Inhibition of CX3CR1 in animal models has been shown to lead to the prevention of atherosclerosis, showing a dramatic reduction in plaque size and composition, consistent with more stable features [21,22,23]. This evidence concerns the gene CX3CR1 and atherosclerosis.